top of page
< Back

Risk of Breast Cancer Recurrence Associated with Carbohydrate Intake and Tissue Expression of IGF-1 Receptor

Emond, Jennifer A.; Pierce, John P.; Natarajan, Loki; Gapuz, Laarni R.; Nguyen, John; Parker, Barbara A.; Varki, Nissi M.; Patterson, Ruth E.

Date Published:





Extra Links:

April 22, 2014


Publisher: American Association for Cancer Research Section: Research Article PMID: 24755714


Background: The insulin-like growth factor-1 (IGF-1) receptor is a potential target for breast cancer treatment and may be influenced by dietary intake. Methods: Nested, case-control study of 265 postmenopausal breast cancer survivors; primary breast cancer tissue was stained to determine IGF-1 receptor status. Change in carbohydrate intake from baseline to Year 1 of study was estimated from 24-hour dietary recalls. Breast cancer recurrence cases (91) were matched to 2 controls (n=174) on disease and study characteristics and counter-matched on change in carbohydrate intake. Weighted conditional logistic regression models fit the risk of recurrence on IGF-1 receptor status and dietary change. Results: Half of tumors were IGF-1 receptor positive. Increased risk of recurrence was associated with IGF-1 receptor positive status (HR 1.7; 95% CI: 1.2-2.5) and, separately, with a stable/increased intake of carbohydrates (HR 2.0; 95% CI: 1.3 5.0). There was a borderline significant interaction between those two variables (p=0.11). Specifically, carbohydrate intake had no significant impact on risk of recurrence among women who were receptor negative, yet increased the risk of recurrence by over 5-fold among women who were receptor positive (HR 5.5; 95% CI 1.8-16.3). Conclusions: Among women whose tumor tissue is positive for the IGF 1 receptor, reducing carbohydrate intake after diagnosis could reduce the risk of breast cancer recurrence. These findings need replication in a larger sample. Impact: This is the first study to suggest that it may be possible to personalize dietary recommendations for breast cancer survivors based on molecular characteristics of their primary tumor tissue.

Automatic Tags

bottom of page